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Mutations in FLCN cause Birt-Hogg-Dubé syndrome, an autosomal dominant disorder notable for development of
cutaneous fibrofolliculomas or trichodiscomas, a variety of renal tumors, and spontaneous pneumothorax due to
cystic lung changes. We present a woman referred for genetic evaluation due to bilateral parotid gland tumors,
who was subsequently diagnosed with Birt-Hogg-Dubé syndrome.
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BHD syndrome is an uncommon genodermatosis char-
acterized by the presence of multiple fibrofolliculomas,
trichodiscomas, and acrochordons of the skin. There is
significantly increased susceptibility to renal tumors, of
which about half are hybrid chromophobe/oncocytic
renal cancers; about 5% are oncocytomas. Pulmonary
cysts occur in the majority of adults with BHD syn-
drome, leading to spontaneous pneumothorax in at least
a quarter of affected individuals. A longer list of tumors
have been reported rarely in BHD [1]; parotid tumors
have been reported several times but have not served as
the sentinel lesion bringing a patient to diagnosis.
Case report
A previously healthy 45 year old Caucasian woman had a
magnetic resonance scan for persistent mild hearing loss in
her right ear. The cause for the hearing loss was not identi-
fied but the magnetic resonance imaging demonstrated
multiple small parotid masses: a 9 mm diameter peripher-
ally enhancing/T2 hyperintense lesion in anterolateral as-
pect of right parotid gland, a few additional smaller T1
hypointense nonenhancing lesions in right parotid gland
and additional lesions in the superficial and deep lobes of
the left parotid gland (Figure 1). Fine needle aspiration bi-
opsies revealed a mildly hypercellular collection of epithe-
lial cells with oncocytic differentiation and associated* Correspondence: nlindor@mayo.edu
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reproduction in any medium, provided the orlymphoid aggregates; the interpretation was: suspicious
for oncocytic neoplasm, favor Warthin tumor. The dif-
ferential diagnosis included the spectrum of oncocytic
proliferations which includes Warthin tumors, nodular
oncocytic hyperplasia (nodular oncocytosis), and mul-
tiple oncocytomas of the parotid glands. The presence of
lymphoid aggregates favors the diagnosis of Warthin
tumors. The histologic diagnosis could not be further
refined based upon the tissues obtained. Given the FNA
findings and the distribution of the lesions, the plan is
for observation of the parotid nodules until bothersome
(size, cosmesis) and the treatment will require surgery
addressing both the superficial and deep lobes of the
parotid gland given the diffuse distribution of the
nodules. She reported no prior history of tumors but
had had several “moles” removed from her face for cos-
metic reasons which were labeled only as “benign”.
There was no history of spontaneous pneumothorax.
The family history was notable for maternal grand-
father with prostate cancer, maternal grandmother with
a bladder cancer diagnosed in her 40s and a lung cancer
diagnosed in her 50s (she had smoked). A maternal
uncle had a throat cancer and died at 58. The paternal
family history was negative for neoplasms. Her three sib-
lings and two children were apparently healthy.
Her physical examination was normal except for a
striking number of raised, smooth, flesh-colored cutane-
ous papules most notable around the scalp (Figure 2)
and face in a generalized distribution and around the
neck accompanied by numerous acrochordons. No
intraoral lesions were noted. Skin biopsies showedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Axial T1 image demonstrating the largest right
parotid nodule near the anterior edge of the gland with a
small nodule in the posterior gland and a nodule in the left
anterior parotid gland.
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acrochordons on the neck. Imaging of the kidneys by
computerized tomography showed only a single small
cyst, but the bases of the lungs showed extensive cystic
changes. Mutation analysis of FLCN revealed a
c.779 + 1 G>T mutation which has been reported previ-
ously in BHD syndrome. Tissue from the biopsy was not
available for further studies such as loss of heterozygos-
ity of FLCN.
Discussion
Parotid gland oncocytic lesions include a spectrum of
histologic findings including nodular oncocytic hyperpla-
sia, benign oncocytoma, and oncocytic carcinoma, and it
may be reasonable to include Warthin tumor some-
where in this spectrum. Nodular oncocytic hyperplasia,
if this is the correct description of the case comprises
only 0.1% of parotid gland diseases [2] while 0.7% of
3,500 salivary gland tumors in another series contained
benign oncocytic lesions [3]. There are a number ofFigure 2 Inset: Whitish papules surrounding follicular orifice,
especially prominent within anterior scalp hairline.individual case reports suggesting that this disorder
appears to be so uncommon as to warrant single case
report presentations. Warthin tumors (also called papil-
lary cystadenoma lymphomatosum, adenolymphomas, or
cystadenolymphomas) are not so rare, being the second
most common tumor of salivary glands (after pleo-
morphic adenomas), and characteristically affect older
males, and are uncommonly bilateral.
A solitary parotid oncocytoma was reported in a
56 year old man with Birt-Hogg-Dubé's syndrome [4]. In
2005, Schmidt et al., reported on 219 individuals with
BHD syndrome studied at that National Cancer Institute
and parotid tumors were reported in two women (ages
62 and 72) and two men (ages 20 and 39). Three of these
were oncocytomas but no information about multiplicity
was provided [5]. Palmirotta et al., reported on two new
BHD families and one woman had a parotid pleo-
morphic adenoma at age 43 [6]. In 2008, Toro et al.,
reported on 51 families (50 were new) with 89 gene mu-
tation carriers and in this series two individuals has par-
otid gland oncocytomas,at ages 20 and 39 (it is not clear
if this overlapped the Schmidt study or if the same ages
were coincidental) [7]. Finally, Maffé et al., reported two
parotid tumors among 19 patients with suspected Birt–
Hogg–Dubé syndrome: a Warthin parotid tumor occurred
in a 59 year old male in whom no FLNC mutation was
found; and of most relavance to the current report, bilat-
eral parotid tumors not otherwise specified, occurred at
ages 32 and 43 years old in one man with a documented
FLNC mutation [8].
Finding an oncocytic tumor in the parotid is of inter-
est as the renal tumors which are characteristic of BHD
often contain oncocytic cells. The relevance of this simi-
larity is obscure. Oncocytic neoplasms, in general, are
thought to result from cells that accumulate abundant
mitochondria in their cytoplasm to form oncocytes via
oncocytic metaplasia. They account for less than 1% of
salivary gland tumors and can occur in other organs in-
cluding kidneys, thyroid and parathyroid glands [9].
Molecular studies of Warthin tumors of the salivary
glands indicate a recurrent t(11;19) translocation with
associated CRTC1-MAML2 fusion oncogene in a subset
of Warthin tumors [10]. We were not able to study this
biopsy for this finding. The chromosomal location of
FLCN is 17p11.2 so no direct link to this translocated re-
gion is evident. Comparative genomic hybridization
studies of salivary tumors did show some tumors with
deletions involving 17p11.2 region in apparently 6 of 15
Warthin tumors but details in that publication were in-
sufficient to determine if FLCN was deleted or not [11].
The function of FLCN is still a matter of investigation.
Baba et al., [12] have studied the protein and stated that
“the interaction of FLCN with FNIP1 and AMPK sug-
gests a possible role for FLCN and FNIP1 in the
Figure 3 Face and forehead. Follicle-based, papular appearance of cheeks and forehead.
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mTOR and may provide a molecular mechanism for the
BHD phenotype”. No direct link to mitochondrial dys-
function has been proposed yet for this tumor suppres-
sor gene but the oncocytic nature of the tumors in both
kidney and now parotid gland raise this as a possibility.
Around half of BHD families recognized to date have
a mutation in hot spot involving deletion (c.1285delC)
or duplication (c.1285dupC) of a C nucleotide in the
polycytosine tract in exon 11 of FLCN [5]. The muta-
tion found in this patient is not in this area but has
been reported previously in six individuals from two
families [as IVS7 + 1] [7] and has not been reported
since, per the Leiden Open Variome Database update of
2011 [https://grenada.lumc.nl/LOVD2/shared1/variants.
php?select_db=FLCN&action=view_unique]. The major
manifestation in these families generally appeared typ-
ical of BHD syndrome with renal tumors in five, lung
cysts in six, documented fibrofolliculomas in five. Also
reported was an angiofibroma, dermatofibrosarcoma
protuberans, cutaneous leiomyosarcoma, and trichodis-
coma. No parotid tumors were reported. Combined with
the current case report, these families might be per-
ceived as having more diverse dermatological findingsthan other BHD families, raising the possibility of some
genotype-phenotype interaction.
Based upon the DNA diagnosis, the patient was coun-
seled regarding autosomal dominant inheritance of this
syndrome and the implications for multiple relatives,
and was provided screening recommendations) for
typical BHD syndrome with regard to renal and pul-
monary complications, and she will remain under
closer surveillance for changes in the parotid tumors
and for additional dermatologic findings [13].Consent
Written consent for use of patient photographs were
obtained.
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